Importance of Prostate Cancer Screenings

Importance of Prostate Cancer Screenings

Julie Scott, DNP
Julie Scott, DNP

What is a Prostate gland?

The prostate is a gland which is part of the male reproductive system. Its job is to produce fluid that is part of the semen. When cells in the prostate begin to grow out of control, cancer develops. The risk for developing prostate cancer increases as men age. To screen for prostate cancer, a blood test called a PSA (prostate specific antigen), and a digital rectal examination may be done.

 

Who should be screened?

According to the U.S. Preventive Services Task Force (USPSTF), the group who provides guidelines for health screening services in the U.S., suggest the following for prostate cancer screening:

● Men aged 55-69 years old should make an individual decision about getting PSA screening. They should have this conversation with their healthcare team about the risks and benefits of screening

● Men over the age of 70 should not be routinely screened

 

The potential risks of screening include getting a false-positive result, which would then lead to unnecessary tests such as imaging studies and biopsies. For some men, screening will find prostate cancer that would otherwise not have caused them any significant health problems. This could then lead to treatment of their cancer that puts them at risk of developing side effects.

Screening Guidelines.

The American Cancer Society suggests a variation to the USPSTF guidelines above. They suggest that the discussion of screening should be held at the following times:

● Age 40 for those at highest risk, meaning men with more than one first-degree relative with prostate cancer diagnosed at an early age (younger than age 65)

● Age 45 for men at high risk, those who are African American men, and those with a first degree relative who have been diagnosed with prostate cancer younger than age 65

● Age 50 for men at average risk and who are expected to live at least 10 more

 

In conclusion, prostate cancer is a serious disease that affects many men. However, there are ways to reduce your risk of developing prostate cancer, including getting screened regularly. You should talk to your doctor about whether or not you should be getting screened for prostate cancer based on your personal risk factors.

Increasing awareness of the importance of early detection and screening can help save the lives of those affected by prostate cancer.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
What are clinical trials and why are they important?
December 22, 2022

Clinical trials are research studies to help find new cancer treatments. Every medication or treatment must go through clinical trials to be approved. Clinical trials are an important part of cancer care. There are different phases to clinical trials. Phase I trials are also called dose-finding trials. During this phase,…

Julie Scott, DNP

author

Articles
The future of early detection- Liquid biopsy
November 7, 2022

Cancer is a frightening disease that impacts many people worldwide, a molecular disorder characterized by the corruption of genetic information at the cellular level, with consequences resulting in changes to critical proteins and molecular circuits. While many treatment options are available, early detection is key to successful treatment; liquid biopsies…

Vino Cherian

administrator

Articles
What is mantle cell lymphoma?
December 22, 2022

Mantle cell lymphoma is a type of non-Hodgkin's lymphoma cancer that grows in the lymphatic system. The lymphatic system is responsible for moving fluids around the body and transporting the immune system. Mantle cell lymphoma is not common and is responsible for less than 10% of lymphoma diagnoses. It’s most…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice